Armata Pharmaceuticals, Inc. Made Headway

Armata Pharmaceuticals, Inc. (ARMP:NYSEMKT) jumped higher at $2.37, representing a gain of 75.6%. On Mon, May 19, 2025, ARMP:NYSEMKT touched a New 2-Week High of $2.37. The stock got featured on our News Catalysts scanner on Mon, May 19, 2025 at 07:38 AM in the 'BIOTECH' category. From Mon, May 05, 2025, the stock recorded 40.00% Up Days and 45.45% Green Days

About Armata Pharmaceuticals, Inc. (ARMP:NYSEMKT)

Ampliphi Biosciences Corp is a clinical-stage biotechnology company focused on the development of bacteriophage-based therapies for the treatment of antibiotic-resistant bacterial infections. The company is developing phage product candidates using a proprietary discovery and development platform, which is designed for rapid identification, characterization, and manufacturing of multiple phage therapeutics. The lead product candidates are AB-SA01 for the treatment of Staphylococcus aureus infections; and AB-PA01 for the treatment of Paeruginosa infections.